IOVA vs BIIB: Which Stock is Better?
Side-by-side comparison of Iovance Biotherapeutics Inc and Biogen Inc in 2026
IOVA
Iovance Biotherapeutics Inc
$3.64
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | IOVA | BIIB | Winner |
|---|---|---|---|
| Market Cap | $1.43B | $26.26B | BIIB |
| P/E Ratio | N/A | 20.38 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.2% | -0.1% | IOVA |
| Gross Margin | 34.3% | 78.9% | BIIB |
Analyze IOVA
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IOVA or BIIB a better investment?
Comparing IOVA and BIIB: Iovance Biotherapeutics Inc has a market cap of $1.43B while Biogen Inc has $26.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IOVA and BIIB?
IOVA (Iovance Biotherapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IOVA or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IOVA or BIIB?
IOVA has higher revenue growth at 0.2% vs -0.1% for BIIB.
Which company is more profitable: IOVA or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 34.3% for IOVA.
Which is the larger company: IOVA or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.26B compared to $1.43B for IOVA.
Should I buy IOVA or BIIB in 2026?
Both IOVA and BIIB have investment merit. IOVA trades at $3.64 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IOVA and BIIB stock?
Key differences: Market Cap ($1.43B vs $26.26B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.2% vs -0.1%), Gross Margin (34.3% vs 78.9%).